Advertising Disclosure — The Weight Verdict is a professional review and comparison website supported by referral fees from the companies featured on this site. Full disclosure

Found Review: the one GLP-1 program with published results and an insurance card

Found is the standout in this category and it is not close. It is the only major GLP-1 telehealth program with a peer-reviewed, published outcome study behind it — 66,094 patients — the only one that bills your insurance for the medication, and the only one that will hand you FDA-approved branded Wegovy or Zepbound instead of a compounded substitute. If your plan covers GLP-1s, this is the easiest recommendation on this site.

13.9% average loss at 12 months (GLP-1 users, peer-reviewed)App Store 4.7 / 5 (8.7K ratings)BBB accredited, A+Bills major insurers in all 50 states
See Found’s current plans and pricing →Our full review continues below
Found bills major insurance carriers for GLP-1 medication, but the membership fee itself is not covered
Before you read on — what "compounded" means. Compounded semaglutide and tirzepatide are not FDA-approved. The FDA has not reviewed them for safety, effectiveness, or quality, and they are not the same as the branded products your doctor may have discussed with you. In April 2026 the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulk substances list, and it has issued three waves of warning letters to telehealth marketers in this category since September 2025. Anyone comparing these programs should assume the rules may change again. This page is information, not medical advice.
4.6/ 5
Found — our #1 GLP-1 telehealth program of 2026
★★★★½
Our score is based on published outcome data, third-party ratings, formulary breadth, pricing transparency and refund terms.
See Found’s current plans and pricing →

What third-party reviewers say

Found's Trustpilot listing read 3.5 out of 5 from 663 reviews in March 2026 and has since climbed to about 3.9 (“Great”) as of late July. Separately it holds 4.7 out of 5 from about 8,700 ratings on the Apple App Store and 4.5 from roughly 1,570 reviews on Google Play, where the app has passed 50,000 downloads. The Better Business Bureau lists Found as accredited since 29 April 2024 with an A+ rating, alongside 89 complaints closed in three years, 54 of them in the last twelve months.

How to read that split. A 4.7 app rating and a 3.5 Trustpilot rating are not contradictory. App reviews are written by people using the product day to day; Trustpilot reviews in this category are overwhelmingly written by people with a billing, cancellation or refund problem. Read the Trustpilot reviews for what can go wrong and the app reviews for what the experience is like when it goes right.
3.9
Trustpilot
~700 reviews
Read them yourself

Billing and charges

The most common negative theme across this whole category, and Found is not exempt: unexpected renewal charges and confusion over what the membership fee does and does not include.

Found answers back

Found responds to about 92% of its negative reviews — unusually high. Public replies are not the same as resolution, but they do mean complaints are being read.

The clinical side reviews well

Positive reviews concentrate on clinician access, the app and the coaching content, which lines up with the 4.7 App Store score.

Sources: Trustpilot (joinfound.com), Apple App Store (Found Health, Inc.), Google Play and the BBB profile for Found. The newest Trustpilot reviews we could surface were dated 21 March 2026, so the live page may show more.

Pricing: $99/month cash, applied at checkout

Found's three pricing routes: $99 a month cash applied at checkout, insurance copays around $30, and Medicare from $50

Start with the good news, because it is genuinely good. If your plan covers GLP-1s, Found bills it and members commonly report copays around $30 — on branded, FDA-approved medication. That is a price no cash-pay compounded program on this site can touch, on a product none of them can supply. And if you are paying cash, Found’s compounded plans start at $99/month — a promotional rate applied at checkout — and that price is clear and consistent.

There are three routes to a Found prescription and they price very differently. Here they are, so you know which one you are on before you enter a card:

How you are payingWhat it costs
CashFrom $99/month. The $99 rate is a promotion applied at checkout. Compounded medication is included and the price is clear and consistent.
Commercial insuranceFound bills your plan for the medication and members with coverage commonly report copays around $30 — on branded product. The Found membership fee is separate and is not billable to insurance.
Medicare Part DBrand-name GLP-1s from a $50/month medication copay under Found’s Medicare GLP-1 Bridge Program, for eligible members aged 65–75, plus a Found membership.
One thing to do anyway. The $99 cash rate is a promotion applied at checkout, so the figure on the final checkout screen is the one that counts — read it before you enter a card. Medication availability still varies by state.

For branded medication paid in cash, Found’s own materials cite roughly $1,100/month for Ozempic and Mounjaro and “from $650/month” for Wegovy and Zepbound. A Found press release dated 14 May 2025 quoted materially lower figures — $499/month for Wegovy and $349–$699 for Zepbound vials. We could not establish which set is current, so we are reporting both rather than picking one.

How the insurance billing actually works

Found is in-network with Aetna, Anthem Blue Cross Blue Shield, Cigna and UnitedHealthcare plus a number of regional plans, and it announced in October 2024 that this reached more than 100 million covered lives. Where coverage applies, members typically report a copay around $30 for the medication itself.

Two caveats that matter more than the headline:

What insurance does cover

  • The GLP-1 prescription itself, where your plan covers GLP-1s for weight management and you meet its criteria.
  • Copays as low as around $30 in the plans we could find member reports for.
  • Branded product — this is the only program on this site where branded Wegovy or Zepbound is realistically affordable.

What it does not cover

  • The Found membership fee. Found states this directly: the subscription fee is not covered by insurance.
  • California. At the time of checking, Found’s insurance flow showed no plans available in California.
  • Lab work, where required. We could not establish a published lab cost.
  • Plans that exclude weight-management drugs entirely — which is a large share of employer plans.

What you can actually be prescribed

Found advertises “15+ medications,” which is broader than the compounded-only programs. In practice that breaks into three groups: branded GLP-1s (Wegovy, Ozempic, Saxenda, Victoza, Zepbound, Mounjaro and Foundayo); compounded semaglutide and tirzepatide, dispensed through 503A pharmacies only; and non-GLP-1 options including metformin, topiramate, Contrave, bupropion and naltrexone.

Found also markets Foundayo™, an oral GLP-1. It is worth being precise about what that is: Foundayo is Eli Lilly’s orforglipron, the first oral GLP-1 approved by the FDA for weight loss, cleared on 1 April 2026. It is a branded, FDA-approved product — not something Found formulates. Lilly lists it from $149/month self-pay, $25/month with a commercial savings card, and $50/month under Medicare Part D from 1 July 2026. As of 4 August 2026 Found is dispensing it: its Medicare GLP-1 Bridge Program lists Foundayo alongside Wegovy and Zepbound for eligible Part D members aged 65–75, at a medication copay from $50/month on top of a Found membership from $49/month — about $99/month all in. Read the program terms before assuming you qualify: eligibility is set by the program rather than by your plan, the $50 copay does not count toward your Part D deductible or out-of-pocket maximum, Low Income Subsidy and Extra Help do not apply, and Found is not affiliated with or endorsed by CMS.

On the compounded side, Found’s own disclosure is unusually direct, and we will quote it because it is the correct framing: “Compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy, and not available in all states.”

Refunds, cancellation and the fine print

Found offers a full refund only within three days of purchase, or before your first clinician consultation, or if you are medically disqualified. After that, renewals, dispensed medication and lab kits are non-refundable.

A correction to something you will read elsewhere. Several affiliate pages still describe a $99 Found cancellation fee. That charge does not appear anywhere in Found’s current terms, so we are not repeating it — and it should not be confused with the $99 promotional cash price, which is what you pay, not a penalty. If you see the fee quoted, check the date on the page.

Who is behind Found

Found has raised roughly $132 million and has been led by CEO Luca Ranaldi since July 2024. It claimed more than 250,000 patients as of October 2024. Found is not itself a medical provider — care is delivered by contracted practices, specifically Pippen Health and Cloud Health Medical Group. That structure is normal in telehealth but it does mean your clinician relationship is with the practice, not with Found.

Found has published an outcomes study in Obesity Science & Practice (January 2025, n = 66,094) reporting roughly 10% mean weight loss at twelve months — 13.9% among GLP-1 users versus 8% among non-GLP-1 users. It is peer-reviewed, which is more than any competitor on this site offers, but the authors are Found-affiliated and the data is Found’s own. Read it as a strong company-generated signal rather than as independent evidence.

Regulatory record: we found no FTC action, no class action and no lawsuit against Found. One point of confusion worth clearing up — the FTC’s enforcement action against NextMed, which reached a final order in December 2025, involves a different company entirely and has nothing to do with Found.

Check whether your insurance is in-network with Found →

Who Found is right for

Sign up if

  • You have commercial insurance through Aetna, Anthem BCBS, Cigna or UnitedHealthcare and want branded Wegovy or Zepbound rather than a compounded copy.
  • You want a clinician who can also prescribe non-GLP-1 options if a GLP-1 is not right for you.
  • You want an app and structured coaching alongside the prescription.
  • You would rather deal with a company that actually answers its critics in public.

Look elsewhere if

  • You want one flat all-in number with no separate membership fee sitting alongside the medication cost — bmiMD charges $99 for a one-month supply and nothing else, though without the branded formulary or the published outcome data.
  • You are in California, where the insurance flow showed no available plans when we checked.
  • You need your price confirmed before you reach checkout — the $99 cash rate is a promotion that is applied on the final checkout screen.
  • You want a branded GLP-1 with no compounded product involved and you have neither insurance coverage for it nor Medicare eligibility — the branded cash prices are in the hundreds.

Frequently asked questions

Does Found take insurance?

Yes, for the medication. Found is in-network with Aetna, Anthem BCBS, Cigna, UnitedHealthcare and several regional plans, and members with coverage commonly report copays around $30. Found's own membership fee is not covered by insurance — you pay that separately.

How much does Found cost?

Pricing starts at $99/month. That rate is a promotion applied at checkout and is clear and consistent. If Found can bill your insurance, the medication goes through your plan and members with coverage commonly report copays around $30, and eligible Medicare Part D members can get brand-name GLP-1s from a $50/month medication copay. The Found membership fee is billed separately from the medication. Confirm the final figure on the checkout screen before you pay.

Is Found legitimate?

Yes, and it has the strongest paper trail of any program we cover. Found is BBB-accredited with an A+ rating, has raised about $132 million from investors including WestCap, IVP and GV, claims more than 250,000 patients, and is the only program on this site to have published a peer-reviewed outcomes study. We found no FTC action, class action or lawsuit against it. Its Trustpilot score of 3.5 reflects billing friction rather than any question about whether the service works.

Does Found actually work?

It is the only program on this site that has published evidence either way. A peer-reviewed study of 66,094 Found patients in Obesity Science & Practice reported roughly 10% mean weight loss at twelve months across the whole cohort and 13.9% among GLP-1 users, with 82.9% maintaining their loss over the year. The study is Found-authored on Found's own data, so read it as a strong company-generated signal rather than as independent evidence — but no competitor has published anything to compare it against.

Can I cancel Found and get a refund?

A full refund is available only within three days of purchase, before your first consultation, or if you are medically disqualified. After that, renewals, dispensed medication and lab kits are non-refundable.

Does Found prescribe branded Wegovy and Zepbound, or compounded copies?

Both. Found's formulary includes branded Wegovy, Ozempic, Saxenda, Victoza, Zepbound, Mounjaro and Foundayo, as well as compounded semaglutide and tirzepatide through 503A pharmacies. Compounded products are not FDA-approved.

What is Foundayo?

Foundayo is Eli Lilly's orforglipron, the first oral GLP-1 approved by the FDA for weight loss, cleared on 1 April 2026. It is a branded FDA-approved drug, not a Found in-house product. Found lists it in its Medicare GLP-1 Bridge Program for eligible Part D members aged 65–75, from a $50 monthly medication copay plus membership.

Sources

Figures on this page were checked on 4 August 2026. Prices, promotions and third-party ratings change frequently — always confirm the current price on the provider’s own checkout before you pay.

Go to Found →
Found — bills major insurers
See Plans